As of 2026-04-02, the Fair Value of Tekla Healthcare Opportunities Fund (THQ) is -69.43 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.34 USD, the upside of Tekla Healthcare Opportunities Fund is -500.39%.
With the market price of 17.34 USD and our fair value calculation, Tekla Healthcare Opportunities Fund (THQ) is not a good investment. Investing in THQ stocks now will result in a potential loss of 500.39%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 5Y Avg | |
| Net income | 194.65 | -86.25 | 52.79 | 190.00 | -115.00 | 47.24 |
| YoY growth | 66.88% | -144.31% | 161.20% | 259.94% | -160.53% | 36.64% |
| Market Cap (mil) | 718.05 |
| P/E | |
| Forward P/E |
| EPS | -2.78 |
| Avg earnings growth rate | 36.64% |
| TTM earnings | -115.00 |